Biomarkers for the Prediction and Judgement of Sepsis and Sepsis Complications: A Step towards <i>precision medicine</i>?
Sepsis and septic shock are a major public health concern and are still associated with high rates of morbidity and mortality. Whilst there is growing understanding of different phenotypes and endotypes of sepsis, all too often treatment strategies still only employ a “one-size-fits-all” approach. B...
Main Authors: | Thilo von Groote, Melanie Meersch-Dini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/19/5782 |
Similar Items
-
Precision Medicine and its Role in the Treatment of Sepsis: A Personalised View
by: Lazăr Alexandra, et al.
Published: (2019-08-01) -
Precision Medicine for Neonatal Sepsis
by: Sherrianne Ng, et al.
Published: (2018-07-01) -
Neonatal Sepsis Caused by <i>Streptococcus gallolyticus</i> Complicated with Pulmonary Hypertension: A Case-Report and a Systematic Literature Review
by: Zoi Iliodromiti, et al.
Published: (2022-12-01) -
Presepsin as a sepsis biomarker
by: K. A. Trunova
Published: (2018-05-01) -
<i>Myristica fragrans</i> Extract Inhibits Platelet Desialylation and Activation to Ameliorate Sepsis-Associated Thrombocytopenia in a Murine CLP-Induced Sepsis Model
by: Seong-Hun Jeong, et al.
Published: (2023-05-01)